Dr. Rajeev Kumar

Neonatology | Pediatrics
Ascension Resurrection
7435 W Talcott Ave, 
Chicago, IL 
Clinical Trials:Currently Recruiting for 2 Trials
Offers Telehealth
Ascension Resurrection
7435 W Talcott Ave, 
Chicago, IL 

Overview

Rajeev Kumar is a Neonatologist and a Pediatrics provider in Chicago, Illinois. His top areas of expertise are Meconium Aspiration Syndrome, Gliomatosis Cerebri, and Transient Familial Hyperbilirubinemia.

His clinical research consists of co-authoring 240 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Neonatology
Pediatrics

Licenses

Pediatrics in IL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO

Locations

Ascension Resurrection
7435 W Talcott Ave, Chicago, IL 60631

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

17 Clinical Trials

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Enrollment Status: Recruiting
Publish Date: December 19, 2025
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Enrollment Status: Recruiting
Publish Date: February 28, 2024
A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington's Disease
A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington's Disease
Enrollment Status: Completed
Publish Date: January 13, 2026
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease
Enrollment Status: Active_not_recruiting
Publish Date: October 23, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Active-controlled, Double-blind, Double-dummy, Parallel-group Clinical Trial, Investigating the Efficacy, Safety, and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless)
A Multicenter, Randomized, Active-controlled, Double-blind, Double-dummy, Parallel-group Clinical Trial, Investigating the Efficacy, Safety, and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless)
Enrollment Status: Active_not_recruiting
Publish Date: May 21, 2025
Intervention Type: Drug, Combination product
Study Drugs: ND0612 Solution, Carbidopa, Levodopa
Study Phase: Phase 3
Phase 2a Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Study of Intravenous ANX005 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 2a Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Study of Intravenous ANX005 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Enrollment Status: Completed
Publish Date: January 06, 2025
Intervention Type: Drug
Study Drug: ANX005
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-Controlled, 2-Period Crossover, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral TAK-071 in Parkinson Disease Patients With Cognitive Impairment and an Elevated Risk of Falls
A Randomized, Double-blind, Placebo-Controlled, 2-Period Crossover, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral TAK-071 in Parkinson Disease Patients With Cognitive Impairment and an Elevated Risk of Falls
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drug: TAK-071
Study Phase: Phase 2
A Multicenter, Non-Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Orally Administered ENT-01 in Improving Constipation and Neurologic Symptoms in Patients With Parkinson's Disease and Constipation Over a 14-week Period
A Multicenter, Non-Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Orally Administered ENT-01 in Improving Constipation and Neurologic Symptoms in Patients With Parkinson's Disease and Constipation Over a 14-week Period
Enrollment Status: Terminated
Publish Date: March 19, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
Cutaneous Phosphorlyated α-synuclein Detection as a Biomarker of Synucleinopathy
Cutaneous Phosphorlyated α-synuclein Detection as a Biomarker of Synucleinopathy
Enrollment Status: Completed
Publish Date: January 03, 2024
Intervention Type: Diagnostic test
View 8 Less Clinical Trials

240 Total Publications

Voltage Decay and Capacity Loss in Lithium-Rich Manganese Oxide Cathodes: Atomic Origins, Mesoscopic Heterogeneities, and Macroscopic Evolution.
Voltage Decay and Capacity Loss in Lithium-Rich Manganese Oxide Cathodes: Atomic Origins, Mesoscopic Heterogeneities, and Macroscopic Evolution.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: October 30, 2025
Similar Doctors
Expertise in
4
conditions
Dr. Aloka Patel
Neonatology | Pediatrics
Expertise in
4
conditions
Dr. Aloka Patel
Neonatology | Pediatrics

Rush University Medical Center

1653 W Congress Pkwy, 
Chicago, IL 
 (0.3 miles away)
312-942-6640
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Aloka Patel is a Neonatologist and a Pediatrics provider in Chicago, Illinois. Dr. Patel is highly rated in 4 conditions, according to our data. Her top areas of expertise are Necrotizing Enterocolitis, Premature Infant, Bronchopulmonary Dysplasia, and Viral Gastroenteritis.

Expertise in
2
conditions
Dr. Isabelle De Plaen
Neonatology
Expertise in
2
conditions
Dr. Isabelle De Plaen
Neonatology

Ann & Robert H. Lurie Children's Hospital Of Chicago

225 E Chicago Ave, 
Chicago, IL 
 (3.1 miles away)
312-227-4190
Languages Spoken:
English
See accepted insurances

Isabelle De Plaen is a Neonatologist in Chicago, Illinois. Dr. De Plaen is highly rated in 2 conditions, according to our data. Her top areas of expertise are Necrotizing Enterocolitis, Premature Infant, Retinopathy of Prematurity, and Atresia of Small Intestine.

Expertise in
22
conditions
Dr. Earl Cheng
Pediatrics
Expertise in
22
conditions
Dr. Earl Cheng
Pediatrics

Ann & Robert H. Lurie Children's Hospital Of Chicago

225 E Chicago Ave, 
Chicago, IL 
 (3.1 miles away)
312-227-6340
Languages Spoken:
English
See accepted insurances

Earl Cheng is a Pediatrics provider in Chicago, Illinois. Dr. Cheng is highly rated in 22 conditions, according to our data. His top areas of expertise are Meatal Stenosis, Hypospadias, Intersex, Bladder Reconstruction, and Vaginectomy.

Frequently Asked Questions about Dr. Rajeev Kumar

How do I make an appointment with Dr. Rajeev Kumar?

You can book an appointment with Dr. Rajeev Kumar by calling their office at 773-792-5163. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Rajeev Kumar a top-rated expert for Meconium Aspiration Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rajeev Kumar is classified as an Experienced expert for Meconium Aspiration Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Rajeev Kumar specialize in?

While Dr. Rajeev Kumar is a Neonatology, they have specific expertise in Meconium Aspiration Syndrome, Gliomatosis Cerebri, and Transient Familial Hyperbilirubinemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neonatology.

Does Dr. Rajeev Kumar participate in research or clinical trials?

Yes. Dr. Rajeev Kumar has published 240 articles and abstracts on conditions like Meconium Aspiration Syndrome. You can view a list of Dr. Rajeev Kumar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Rajeev Kumar accept my insurance?

Dr. Rajeev Kumar accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 773-792-5163 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kumar's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile